{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-010083","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.804312+00:00","generated_at":"2026-05-27T03:25:24.038041+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NeuroOne regains Nasdaq compliance; reports record preliminary Q1 revenue of $6.2M","bullets":["Received Nasdaq letter on Feb 3, 2025 confirming cure of bid price deficiency; hearing cancelled.","Preliminary unaudited Q1 FY2025 total revenue of $6.2M (product $3.2M + one-time license $3.0M).","CEO highlights OneRF Ablation System as first FDA-cleared device for RF ablation in the brain.","Earnings call scheduled for February 12, 2025 at 8:30 am ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-010083","json":"https://secwatch.observer/filing/0001213900-25-010083.json","markdown":"https://secwatch.observer/filing/0001213900-25-010083.md","text":"https://secwatch.observer/filing/0001213900-25-010083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025010083/0001213900-25-010083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025010083/ea0229869-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:25:24.038041+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}